These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The role of combination medical therapy in benign prostatic hyperplasia. Greco KA; McVary KT Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123 [TBL] [Abstract][Full Text] [Related]
9. Advances in the development of hormonal modulators for the treatment of benign prostatic hyperplasia. Tiwari A Expert Opin Investig Drugs; 2007 Sep; 16(9):1425-39. PubMed ID: 17714028 [TBL] [Abstract][Full Text] [Related]
11. Advances in the design and discovery of drugs for the treatment of prostatic hyperplasia. Kumar R; Malla P; Kumar M Expert Opin Drug Discov; 2013 Aug; 8(8):1013-27. PubMed ID: 23662859 [TBL] [Abstract][Full Text] [Related]
12. New drugs for the prostate. Harv Mens Health Watch; 2005 Jun; 9(11):3-8. PubMed ID: 16138402 [No Abstract] [Full Text] [Related]
13. [Drugs for the treatment of benign prostatic hypertrophy]. Caprino L Minerva Urol Nefrol; 2000 Jun; 52(2):87-92. PubMed ID: 11085067 [TBL] [Abstract][Full Text] [Related]
14. Current role for combination therapy in male LUTS. Chung DE; Kaplan SA Arch Esp Urol; 2010 Jun; 63(5):323-32. PubMed ID: 20587837 [TBL] [Abstract][Full Text] [Related]
15. Trends in the development of new drugs for treatment of benign prostatic hyperplasia. Kulig K; Malawska B Curr Med Chem; 2006; 13(28):3395-416. PubMed ID: 17168713 [TBL] [Abstract][Full Text] [Related]
17. [Combination therapy in benign prostatic hyperplasia (BPH)]. Desgrandchamps F Ann Urol (Paris); 2004 Dec; 38 Suppl 2():S24-8. PubMed ID: 15651487 [TBL] [Abstract][Full Text] [Related]
18. An evidence-based approach to understanding the pharmacological class effect in the management of prostatic diseases. Evans CP; Fleshner N; Fitzpatrick JM; Zlotta AR BJU Int; 2005 Apr; 95(6):743-9. PubMed ID: 15794775 [No Abstract] [Full Text] [Related]
19. NX-1207: a novel investigational drug for the treatment of benign prostatic hyperplasia. Shore N Expert Opin Investig Drugs; 2010 Feb; 19(2):305-10. PubMed ID: 20050813 [TBL] [Abstract][Full Text] [Related]
20. Alpha-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia. Cooper KL; McKiernan JM; Kaplan SA Drugs; 1999 Jan; 57(1):9-17. PubMed ID: 9951948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]